An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Medha Chadha and Jason Schoenholtz Join Lazard as Managing Directors, Healthcare Advisory Group
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Lazard Ltd (NYSE: LAZ) has appointed Medha Chadha and Jason Schoenholtz as Managing Directors in Financial Advisory, focusing on healthcare clients. Ms. Chadha will lead capital markets advisory, leveraging 16 years of equity capital markets experience, particularly in biotech. Mr. Schoenholtz, with nearly two decades in healthcare investment banking, will enhance the team's expertise in healthcare services. This strategic expansion aims to improve Lazard’s advisory capabilities in the healthcare sector.
Positive
Appointment of Medha Chadha and Jason Schoenholtz as Managing Directors.
Chadha to enhance capital markets advisory for healthcare.
Schoenholtz to focus on healthcare services, boosting expertise.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Lazard Ltd (NYSE: LAZ) announced today that Medha Chadha and Jason Schoenholtz have joined the firm as Managing Directors in Financial Advisory. Based in New York, they will serve clients of the global healthcare group. Ms. Chadha will lead an expansion of the group’s capital markets advisory capabilities, and Mr. Schoenholtz will be a senior member of the team focusing on healthcare services companies.
“Medha and Jason each bring differentiated experience and skills to our team, which we expect will deliver substantial benefits for our healthcare clients,” said David Gluckman, a Vice Chairman of Investment Banking and Global Head of the Healthcare Group. “Medha brings 16 years of involvement in the equity capital markets, with specific expertise in biotech and tech-enabled healthcare services companies, and Jason has almost two decades of experience in healthcare investment banking, with a deep focus on healthcare services and extensive relationships in private equity.”
Prior to joining Lazard, Ms. Chadha was SVP of Corporate Planning and Investor Relations at AlloVir, an ElevateBio company, since 2020. Before that, she was U.S. Head of Equity Capital Markets Syndicate for Cantor Fitzgerald, which she joined in 2017. She began her investment banking career in 2004 at Credit Suisse.
Mr. Schoenholtz joins Lazard from Cantor Fitzgerald, where he was a Managing Director in the Healthcare Investment Banking Group since 2016. Prior to that, he served as a Managing Director in the healthcare group of RBC Capital Markets since 2012. He has worked in the healthcare groups of Credit Suisse and Goldman Sachs and began his investment banking career at UBS in 2002.
About Lazard
Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 41 cities across 26 countries in North America, Europe, Asia, Australia, Central and South America. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard.
